Rapid advances in cancer immunotherapy (I-O) offer novel treatment opportunities for patients. It also creates new challenges for clinicians aiming to offer the most suitable treatment based on a precise diagnosis and an informed decision-making process. To stimulate the exchange with international colleagues and to learn from experiences gained in other Cancer Centers, Oslo Cancer […]